Tenderwize
Back to tender search

Open house pharmaceutical rebate agreements for Alfacalcidol, ATC A11CC03

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 03, 2027 · 474 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Alfacalcidol, ATC A11CC03

60/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

Agreements can be automatically superseded by future competitive rebate contracts, reducing potential volume.

Strict submission requirements: paper must be 2 copies, hand-signed; electronic requires qualified signature; both must...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Non-exclusive pharmaceutical rebate agreements (Rabattverträge) under §130a(8) SGB V
  • Active substance: Alfacalcidol, ATC code A11CC03
Show full summary

Open house non-exclusive rebate agreement for the active ingredient Alfacalcidol (ATC A11CC03) by AOK Bayern. All interested pharmaceutical companies meeting eligibility criteria can join. No competitive selection; contract terms are fixed. Early contract start possible from 01.02.2026, with all contracts ending 31.01.2028. Final date for contract conclusion is 03.12.2027.

Risks

Agreements can be automatically superseded by future competitive rebate contracts, reducing potential volume.

Strict submission requirements: paper must be 2 copies, hand-signed; electronic requires qualified signature; both must...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible

Certifications

  • Documents must be in German or accompanied by a certified German translation

Administrative

  • Submit signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria - all eligible companies can join.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house pharmaceutical rebate agreements for Alfacalcidol, ATC A11CC03

Non-exclusive rebate agreements for the active ingredient Alfacalcidol. Open to all qualified pharmaceutical companies. Contract duration 24 months. Submission monthly by the 3rd for next month start. No award criteria or competition.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jan 2026 - Jan 2028

Category

Pharmaceutical products

Award Criteria

No award criteria - all eligible companies can join.

Deadline

Deadline Dec 03, 2027

Procurement Details

Publication date
14 Dec 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
829127-2025

Documents (2)

Similar tenders